Chen Lih-Lian, Lee Mei-Hsien, Chang Chia-Lin, Liou Kuo-Tong, Liu Shu-Hsiang, Chern Chang-Ming, Chen Hui-I, Shen Yuh-Chiang, Wang Yea-Hwey
Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei City, Taiwan.
Department of Traditional Chinese Medicine, En Chu Kong Hospital, New Taipei City, Taiwan.
Evid Based Complement Alternat Med. 2021 Dec 22;2021:5205759. doi: 10.1155/2021/5205759. eCollection 2021.
Cinnamon () is a well-known traditional Chinese medicine used to treat nocturia by tonifying and warming the kidney. Our recent clinical study found that overactive bladder (OAB) patients treated with cinnamon powder (CNP) patches exhibited significantly ameliorated OAB symptoms without significant side effects, but the mechanism of action is unclear. To explore the beneficial effects and action mechanisms of CNP and its major active component cinnamaldehyde (CNA) in an OAB-related murine model, cyclophosphamide- (CYP-) induced OAB injury was performed on male in the presence or absence of CNP and CNA, as well as solifenacin, a clinical drug for OAB as a reference. Twenty-four-hour micturition patterns (frequency of urination and volume of urine per time), as well as histopathological examination, immunohistochemistry (IHC), and Western blotting of the bladder, were analyzed for mechanism elucidation. Administration of CYP (300 mg/kg, i.p.) induced typical OAB pathophysiological changes, including increased frequency of urination and reduced volume of urine. CYP-induced mice displayed strong edema of the bladder and hemorrhagic cystitis, accompanied by loss of normal corrugated folds and decreased muscarinic receptors (M2/M3) in the urothelium, and disordered/broken structures of the lamina propria and detrusor. These changes were correlated with increased leukocyte (CD11b) infiltration colocalized with inflammatory (pp65 NFB, macrophage migration inhibitory factor (MIF)TLR4)) and fibrotic (stem cell factor (SCF)/c-Kit, - (-SMA)/-catenin) signals. Treatment with CNP (600 mg/kg, p.o.) and CNA (10-50 mg/kg, p.o.), but not solifenacin (50 mg/kg), 30 min after CYP induction significantly ameliorated CYP-induced dysfunction in micturition patterns and pathophysiological changes. CNP and CNA further suppressed MIF/TLR4-associated inflammatory and SCF/c-Kit-related fibrotic signaling pathways. Our findings indicate that suppression of inflammatory and fibrotic signals contributes to the crucial mechanism in the improvement of CYP-induced OAB by CNP and CNA.
肉桂是一种著名的传统中药,用于通过补肾温阳来治疗夜尿症。我们最近的临床研究发现,用肉桂粉(CNP)贴片治疗的膀胱过度活动症(OAB)患者的OAB症状得到了显著改善,且无明显副作用,但其作用机制尚不清楚。为了探究CNP及其主要活性成分肉桂醛(CNA)在OAB相关小鼠模型中的有益作用及作用机制,在有或没有CNP、CNA以及作为对照的OAB临床药物索利那新存在的情况下,对雄性小鼠进行环磷酰胺(CYP)诱导的OAB损伤。分析24小时排尿模式(排尿频率和每次尿量)以及膀胱的组织病理学检查、免疫组织化学(IHC)和蛋白质免疫印迹,以阐明作用机制。腹腔注射CYP(300mg/kg)诱导典型的OAB病理生理变化,包括排尿频率增加和尿量减少。CYP诱导的小鼠表现出膀胱强烈水肿和出血性膀胱炎,伴有正常皱襞消失以及尿路上皮中毒蕈碱受体(M2/M3)减少,固有层和逼尿肌结构紊乱/破坏。这些变化与白细胞(CD11b)浸润增加相关,白细胞浸润与炎症信号(pp65 NFκB、巨噬细胞迁移抑制因子(MIF)、Toll样受体4(TLR4))和纤维化信号(干细胞因子(SCF)/c-Kit、α-平滑肌肌动蛋白(α-SMA)/β-连环蛋白)共定位。在CYP诱导后30分钟,用CNP(600mg/kg,口服)和CNA(10 - 50mg/kg,口服)治疗,但不用索利那新(50mg/kg),可显著改善CYP诱导的排尿模式功能障碍和病理生理变化。CNP和CNA进一步抑制了MIF/TLR相关的炎症信号通路和SCF/c-Kit相关的纤维化信号通路。我们的研究结果表明,抑制炎症和纤维化信号是CNP和CNA改善CYP诱导的OAB的关键机制。